InChI=1S/C27H46O5/c1- 15(5- 8- 22(30) 16(2) 14- 28) 19- 6- 7- 20- 25- 21(13- 24(32) 27(19,20) 4) 26(3) 10- 9- 18(29) 11- 17(26) 12- 23(25) 31/h14- 25,29- 32H,5- 13H2,1- 4H3/t15- ,16?,17+,18- ,19- ,20+,21+,22+,23- ,24+,25+,26+,27- /m1/s1 |
MZWYIFQIBJLCBI-CJKJGBPISA-N |
[H] [C@@] 12C[C@H] (O) CC[C@] 1(C) [C@@] 1([H] ) C[C@H] (O) [C@] 3(C) [C@] ([H] ) (CC[C@@] 3([H] ) [C@] 1([H] ) [C@H] (O) C2) [C@H] (C) CC[C@H] (O) C(C) C=O |
|
bile acid metabolite
Metabolites of bile acids, four-ringed steroid acids formed along the cholesterol degradation pathway.
(via 3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-al )
|
|
View more via ChEBI Ontology
Outgoing
|
(24S)-3α,7α,12α,24-tetrahydroxy-5β-cholestan-26-al
(CHEBI:63849)
is a
3α,7α,12α,24-tetrahydroxy-5β-cholestan-26-al
(CHEBI:48735)
|
|
(24S)-3α,7α,12α,24-tetrahydroxy-5β-cholestan-26-al
|
3α,7α,12α,24(S)-tetrahydroxy-5β-cholestan-27-al
|
ChEBI
|
|